Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma

被引:72
作者
Siegemund, T [1 ]
Petros, S [1 ]
Siegemund, A [1 ]
Scholz, U [1 ]
Engelmann, L [1 ]
机构
[1] Univ Leipzig, Med Clin 1, D-04103 Leipzig, Germany
关键词
thrombin generation; haemophilia; factor VIII; factor IX; platelets;
D O I
10.1160/TH03-01-0027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombin generation was investigated in platelet-rich plasma (PRP) from 11 healthy controls, 17 patients with severe haemophilia A and 7 patients with severe haemophilia B. Mean endogenous thrombin potential (ETP) in arbitrary fluorescence units (FU) was 226.9 +/- 44.6, 186.4 +/- 22.5, 154.2 +/- 41.3 in controls, haemophilia A and B, respectively, all at a platelet count of 200 X 10(9)/l (p = 0.004 for controls vs. haemophilia A, p = 0.003 for controls vs. haemophilia B, no significant difference between haemophilia A and B). The contribution of FVIII to thrombin generation in haemophilia A was 1.31 +/- 0.16 FU/% of FVIII:C activity, while for FIX in haemophilia B this was 0.80 +/- 0.21 FU/% of FIX activity. There was an almost linear relationship between increasing platelet count and thrombin generation up to a mean platelet count of 100 x 10(9)/l. Further increase in platelet count has only a marginal influence on thrombin generation. Platelets increase ETP in haemophilia A by 0.184 +/- 0.022 FU/10(9) platelets/l and in haemophilia B by 0.319 +/- 0.085 FU/10(9) platelets/l, and this was significantly different between the two groups (p = 0.0002). This influence of platelets diminishes with increasing concentration of either FVIII or FIX. In conclusion, there is a difference in thrombin generation between haemophilia A and B, and this may be attributed to the role of platelets in the assembly of the tenase complex on their surface.
引用
收藏
页码:781 / 786
页数:6
相关论文
共 35 条
[1]   The thrombogram in rare inherited coagulation disorders:: Its relation to clinical bleeding [J].
Al Dieri, R ;
Peyvandi, F ;
Santagostino, E ;
Giansily, M ;
Mannucci, PM ;
Schved, JF ;
Béguin, S ;
Hemker, HC .
THROMBOSIS AND HAEMOSTASIS, 2002, 88 (04) :576-582
[2]  
BENDETOWICZ AV, 1994, THROMB HAEMOSTASIS, V72, P705
[3]  
Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639
[4]   Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers [J].
Bijsterveld, NR ;
Moons, AH ;
Boekholdt, SM ;
van Aken, BE ;
Fennema, H ;
Peters, RJG ;
Meijers, JCM ;
Büller, HR ;
Levi, M .
CIRCULATION, 2002, 106 (20) :2550-2554
[5]   Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases [J].
Butenas, S ;
vantVeer, C ;
Mann, KG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) :21527-21533
[6]   Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation [J].
Carr, ME ;
Martin, EJ ;
Carr, SL .
BLOOD COAGULATION & FIBRINOLYSIS, 2002, 13 (03) :193-197
[7]   WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING [J].
DAVIE, EW ;
RATNOFF, OD .
SCIENCE, 1964, 145 (363) :1310-&
[8]   FACTOR-XI ACTIVATION IN A REVISED MODEL OF BLOOD-COAGULATION [J].
GAILANI, D ;
BROZE, GJ .
SCIENCE, 1991, 253 (5022) :909-912
[9]  
Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186
[10]  
Hemker HC, 2000, THROMB HAEMOSTASIS, V83, P589